A Look At Roivant Sciences (ROIV) Valuation After Recent Share Price Strength [Yahoo! Finance]
Roivant Sciences (ROIV) had its "buy" rating reaffirmed by TD Cowen.
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang [Yahoo! Finance]
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang [Yahoo! Finance Canada]
Roivant Sciences (ROIV) had its price target raised by HC Wainwright from $33.00 to $34.00. They now have a "buy" rating on the stock.